Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Sabra Health Care REIT, Inc. (SBRA)

18.12 +0.07 (+0.39%)
At close: June 18 at 4:00:01 PM EDT
18.40 +0.28 (+1.55%)
After hours: June 18 at 7:07:16 PM EDT
Trade SBRA on Coinbase
Chart Range Bar
Loading chart for SBRA
  • Previous Close 18.05
  • Open 18.10
  • Bid 13.04 x 200
  • Ask 23.14 x 200
  • Day's Range 17.86 - 18.27
  • 52 Week Range 17.17 - 21.28
  • Volume 5,673,228
  • Avg. Volume 2,519,588
  • Market Cap (intraday) 4.57B
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) 28.76
  • EPS (TTM) 0.63
  • Earnings Date Apr 29, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 22.54

Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.

www.sabrahealth.com

58

Full Time Employees

December 31

Fiscal Year Ends

Real Estate

Sector

Performance Overview

Trailing total returns as of 6/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SBRA
1.50%
S&P 500 (^GSPC)
9.57%

1-Year Return

SBRA
5.44%
S&P 500 (^GSPC)
25.41%

3-Year Return

SBRA
89.82%
S&P 500 (^GSPC)
70.10%

5-Year Return

SBRA
55.12%
S&P 500 (^GSPC)
80.02%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 221.75M
Earnings 41.1M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
50M
100M
150M
200M

Analyst Insights

View More

Analyst Price Targets

19.00
22.54 Average
18.12 Current
25.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/18/2026
Analyst Scotiabank
Rating Action Maintains
Rating Sector Perform
Price Action Lowers
Price Target 22 -> 19

Statistics

View More

Valuation Measures

Annual
As of 6/18/2026
  • Market Cap

    4.57B

  • Enterprise Value

    7.14B

  • Trailing P/E

    28.76

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.54

  • Price/Book (mrq)

    1.64

  • Enterprise Value/Revenue

    8.78

  • Enterprise Value/EBITDA

    15.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.15%

  • Return on Assets (ttm)

    3.09%

  • Return on Equity (ttm)

    5.68%

  • Revenue (ttm)

    815.66M

  • Net Income Avi to Common (ttm)

    156.18M

  • Diluted EPS (ttm)

    0.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    124.18M

  • Total Debt/Equity (mrq)

    95.86%

  • Levered Free Cash Flow (ttm)

    197.84M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

18.12 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • What does Argus have to say about SBRA?

    SABRA HEALTH CARE REIT INC has an Investment Rating of HOLD; a target price of $18.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • What does Argus have to say about SBRA?

    SABRA HEALTH CARE REIT INC has an Investment Rating of HOLD; a target price of $18.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • Lowering target price to $18.00

    SABRA HEALTH CARE REIT INC has an Investment Rating of HOLD; a target price of $18.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • What does Argus have to say about SBRA?

    SABRA HEALTH CARE REIT INC has an Investment Rating of HOLD; a target price of $22.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: